Polymorphisms and expression of toll-like receptors in autoimmune thyroid diseases

References

• Davies, T. 2000. Pathogenesis of Graves' disease. In The Thyroid: A Fundamental and Clinical Text. L. E. Braverman and R. D. Utiger, eds. Lippincott Williams & Wilkins, Philadelphia. p. 518–531
   Google Scholar
• Weetman, A. P. 2000. CHRONIC AUTOIMMUNE THYROIDITIS. In The Thyroid: A Fundamental and Clinical Text. L. Braverman, and R. Utiger, ed. Lippincott Williams & Wilkins, Philadelphia. p. 721–732
   Google Scholar
• Ito, C., M. Watanabe, N. Okuda, et al 2006. Association between the severity of Hashimoto's disease and the functional +874A/T polymorphism in the interferon-gamma gene. Endocr. J. 53: 473–478
   PubMed Web of Science ®Google Scholar
• Nanba, T., M. Watanabe, T. Akamizu, and Y. Iwatani. 2008. The −590CC genotype in the IL4 gene as a strong predictive factor for the development of hypothyroidism in Hashimoto disease. Clin. Chem. 54: 621–623
   PubMed Web of Science ®Google Scholar
• Nanba, T., M. Watanabe, N. Inoue, and Y. Iwatani. 2009. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. Thyroid. 19: 495–501
   PubMed Web of Science ®Google Scholar
• Hayashi, F., M. Watanabe, T. Nanba, et al 2009. Association of the −31C/T functional polymorphism in the interleukin-1beta gene with the intractability of Graves' disease and the proportion of T helper type 17 cells. Clin. Exp. Immunol. 158: 281–286
   PubMed Web of Science ®Google Scholar
• Yamada, H., M. Watanabe, T. Nanba, et al 2008. The +869T/C polymorphism in the transforming growth factor-beta1 gene is associated with the severity and intractability of autoimmune thyroid disease. Clin. Exp. Immunol. 151: 379–382
   PubMed Web of Science ®Google Scholar
• Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942–949
   PubMed Web of Science ®Google Scholar
• Manel, N., D. Unutmaz, and D. R. Littman. 2008. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 9: 641–649
   PubMed Web of Science ®Google Scholar
• Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell. 124: 783–801
   PubMed Web of Science ®Google Scholar
• Saitoh, T., T. Satoh, N. Yamamoto, et al 2011. Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Immunity. 34: 352–363
   PubMed Web of Science ®Google Scholar
• Netea, M. G., C. Van der Graaf, J. W. Van der Meer, and B. J. Kullberg. 2004. Recognition of fungal pathogens by Toll-like receptors. Eur. J. Clin. Microbiol. Infect. Dis. 23: 672–676
   PubMed Web of Science ®Google Scholar
• Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335–376
   PubMed Web of Science ®Google Scholar
• Marshak-Rothstein, A. 2006. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6: 823–835
   PubMed Web of Science ®Google Scholar
• Richez, C., P. Blanco, I. Rifkin, et al 2011. Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus. Joint Bone Spine. 78: 124–130
   PubMed Web of Science ®Google Scholar
• Garcia-Rodriguez, S., S. Arias-Santiago, R. Perandres-Lopez, et al 2011. Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis. J. Eur. Acad. Dermatol. Venereol. 27: 242–250
   Web of Science ®Google Scholar
• Diebold, S. S., T. Kaisho, H. Hemmi, et al 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 303: 1529–1531
   PubMed Web of Science ®Google Scholar
• Heil, F., H. Hemmi, H. Hochrein, et al 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 303: 1526–1529
   PubMed Web of Science ®Google Scholar
• Hemmi, H., O. Takeuchi, T. Kawai, et al 2000. A Toll-like receptor recognizes bacterial DNA. Nature. 408: 740–745
   PubMed Web of Science ®Google Scholar
• Tabeta, K., P. Georgel, E. Janssen, et al 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. U.S.A. 101: 3516–3521
   PubMed Web of Science ®Google Scholar
• Kim, Y. M., M. M. Brinkmann, M. E. Paquet, and H. L. Ploegh. 2008. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature. 452: 234–238
   PubMed Web of Science ®Google Scholar
• Redfern, R. L., N. Patel, S. Hanlon, et al 2011. Toll-like receptor expression and activation in mice with experimental dry eye. Invest. Ophthalmol. Vis. Sci. 54: 1554–1563
   Web of Science ®Google Scholar
• Fukui, R., S. Saitoh, A. Kanno, et al 2011. Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking. Immunity. 35: 69–81
   PubMed Web of Science ®Google Scholar
• Santiago-Raber, M. L., I. Dunand-Sauthier, T. Wu, et al 2010. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J. Autoimmun. 34: 339–348
   PubMed Web of Science ®Google Scholar
• Hornung, V., S. Rothenfusser, S. Britsch, et al 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531–4537
   PubMed Web of Science ®Google Scholar
• Yue, M., C. F. Gao, J. J. Wang, et al 2014. Toll-like receptor 7 variations are associated with the susceptibility to HCV infection among Chinese females. Infect. Genet. Evol. 27: 264–270
   PubMed Web of Science ®Google Scholar
• Shen, N., Q. Fu, Y. Deng, et al 2010. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc. Natl. Acad. Sci. U.S.A. 107: 15838–15843
   PubMed Web of Science ®Google Scholar
• Xiao, W., Z. Liu, J. Lin, et al 2015. Association of Toll-like receptor 7 and 8 gene polymorphisms with Graves' disease in Chinese Cantonese population. Tissue Antigens. 85: 29–34
   PubMedGoogle Scholar
• Bharti, D., A. Kumar, R. S. Mahla, et al 2014. The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis. Immunogenetics. 66: 675–681
   PubMed Web of Science ®Google Scholar
• Kikuchi, K., Z. X. Lian, Y. Kimura, et al 2005. Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis. J. Autoimmun. 24: 347–352
   PubMed Web of Science ®Google Scholar
• Liao, W. L., R. H. Chen, H. J. Lin, et al 2010. Toll-like receptor gene polymorphisms are associated with susceptibility to Graves' ophthalmopathy in Taiwan males. BMC Med. Genet. 11: 154
   PubMed Web of Science ®Google Scholar
• Zhang, J., Q. Zhu, F. Meng, et al 2014. Association study of TLR-9 polymorphisms and systemic lupus erythematosus in northern Chinese Han population. Gene. 533: 385–388
   PubMed Web of Science ®Google Scholar
• Lyon, M. F. 1961. Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature. 190: 372–373
   PubMed Web of Science ®Google Scholar
• Monk, M., and M. Grant. 1990. Preferential X-chromosome inactivation, DNA methylation and imprinting. Dev. Suppl. 55–62
   PubMedGoogle Scholar
• Hammerstad, S. S., F. L. Jahnsen, S. Tauriainen, et al 2013. Inflammation and increased myxovirus resistance protein A expression in thyroid tissue in the early stages of Hashimoto's thyroiditis. Thyroid. 23: 334–341
   PubMed Web of Science ®Google Scholar
• Wei, X. S., C. D. Wei, Y. Q. Tong, et al 2014. Single nucleotide polymorphisms of toll-like receptor 7 and toll-like receptor 9 in hepatitis C virus infection patients from central China. Yonsei Med. J. 55: 428–434
   PubMed Web of Science ®Google Scholar